Stephen Betz
Vermögen: 5 Mio $ am 31.07.2026
Vermögen: 5 Mio $ am 31.07.2026
Stephen F.
Betz is the founder of Crinetics Pharmaceuticals, Inc., founded in 2008, where the title held is Chief Scientific Officer since 2021.
Former jobs include Director-Endocrinology & Metabolism at Neurocrine Biosciences, Inc. from 2003 to 2009, and Head-Laboratory Efforts at GeneFormatics, Inc. from 2001 to 2003.
Education history includes an undergraduate degree from the University of Delaware conferred in 1987 and a doctorate from The University of North Carolina at Chapel Hill conferred in 1993.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.07.2026 | 58.078 ( 0,06 % ) | 5 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Gründer | 01.01.2008 |
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01.05.2009 |
GeneFormatics, Inc.
GeneFormatics, Inc. BiotechnologyHealth Technology Provides protein function determination | Corporate Officer/Principal | 01.01.2003 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
GeneFormatics, Inc.
GeneFormatics, Inc. BiotechnologyHealth Technology Provides protein function determination | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen